why do people microdose glp 1 Microdosing GLP-1s: Does It Work? Risks and Benefits Dr. Blum and our patient

Patients with poorly controlled BP at baseline experience the largest reduction in BP (138)

doi:10.1152/ajpendo.2001.281.1.E155 Garber AJ

Clinical evidences on the DPP-4 inhibitor sitagliptin suggests it is associated with a decreased risk of prostate cancer [106, 110], and long-term administration of this agent may have potential benefits for breast cancer [96]

Follow for more: My Hair MD: myhairmd.com | [email protected] JD's IG: @jd_denham_fit | Will's IG: @williamthaas | Community: skool.com/peptideresearchinstitute Peptide Q&A #39 The Full GH Peptide Breakdown, IGF-1 LR3 Protocols, with Paul Bakhtiar Medical Disclaimer: We are not doctors